Thermo Fisher Scientific ANGPTL4 Polyclonal Antibody

Applications

Tested Dilution

Publications

Western Blot (WB)

2 µg/mL

View 2 publications 2 publications

Product Specifications

Species Reactivity

Mouse, Rat

Published species

Mouse

Host/Isotype

Rabbit / IgG

Class

Polyclonal

Type

Antibody

Immunogen

Synthetic peptide corresponding to residues C(80) Q G P K G K D A P F K D S E(94) of mouse FIAF. if (typeof window.$mangular === undefined || !window.$mangular) { window.$mangular = {}; } $mangular.antigenJson = \[{targetFamily:ANGPTL4,uniProtId:Q9Z1P8-1,ncbiNodeId:10090,antigenRange:81-94,antigenLength:410,antigenImageFileName:PA1-1053_ANGPTL4_Q9Z1P8-1_Rabbit.svg,antigenImageFileNamePDP:PA1-1053_ANGPTL4_Q9Z1P8-1_Rabbit_PDP.jpeg,sortOrder:2}\]; $mangular.isB2BCMGT = false; $mangular.isEpitopesModalImageMultiSizeEnabled = true;

View immunogen .st0{fill:#FFFFFF;} .st1{fill:#1E8AE7;}

Conjugate

Unconjugated Unconjugated Unconjugated

Form

Liquid

Concentration

1 mg/mL

Purification

Antigen affinity chromatography

Storage buffer

PBS with 1mg/mL BSA

Contains

0.05% sodium azide

Storage conditions

-20° C, Avoid Freeze/Thaw Cycles

Shipping conditions

Ambient (domestic); Wet ice (international)

RRID

AB_2057436

Product Specific Information

PA1-1053 detects fasting-induced adipose factor (FIAF) from rat and mouse adipose tissue.

PA1-1053 has been successfully used in Western blot procedures. By Western blot, this antibody detects an ~50 kDa protein representing FIAF from rat adipose tissue extracts.

The PA1-1053 immunogen is a synthetic peptide corresponding to residues C(80) Q G P K G K D A P F K D S E(94) of mouse FIAF.

PA1-1053 can be used with blocking peptide PEP-178.

Target Information

Angiopoietin-like protein 4 (ANGPTL4), is a secreted protein selectively expressed in adipose tissue, liver, and placenta1-3 that plays a variety of roles in vivo, ranging from adipogenesis to angiogenesis to carcinogenesis. The expression of ANGPTL4 is also under nutritional and hormonal control. ANGPTL4 has been observed to induce a strong pro-angiogenic response independent of vascular endothelial growth factor (VEGF), and its expression has been described in hypoxic human tissues as well as a variety of cancers, including liposarcoma, hepatocellular carcinoma, and conventional renal cell carcinoma.

For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.